Protalix BioTherapeutics (PLX)
Protalix BioTherapeutics Valuation Percentage
View PLX Valuation Percentage with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
Learn More
PLX News
Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences
May 29, 7:30AM GlobeNewswire
May 29, 7:30AM GlobeNewswire
@groberjg07 $ARNA $PLX immediately opened on FDA approval and yet we are still halted..
about 21 days ago by BiopharmaPro
about 21 days ago by BiopharmaPro
$PLX http://stks.co/3lrN recovery after the Approval profit taking, will be volatile till the option expiry 5/19
about 21 days ago by gantosj
about 21 days ago by gantosj
Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences
May 10, 7:30AM GlobeNewswire
May 10, 7:30AM GlobeNewswire
$PLX pumper article won't save this thing. massive insider selling tells the story. this wont go above 7.5 imo
about 23 days ago by johnkelly
about 23 days ago by johnkelly
well apparantly $PLX insiders dont think it'll go over $7.50 anytime soon! never seen so much selling lol http://stks.co/3iSq
about 23 days ago by johnkelly
about 23 days ago by johnkelly
$VTUS Phase 3 data for anal fissures, expected by May 15th, 120M market share, no competitor, grossly undervalued $JAZZ $PLX $VVUS $$
about 24 days ago by peterumble
about 24 days ago by peterumble
RT @peterumble Short stocks: $EXEL $RGEN $PLX $POZN $CVM , markets hate uncertainty $SPY- SPY down 3.1% POZN up 0.8% since Wed. close. DD.
about 26 days ago by Glopolon
about 26 days ago by Glopolon
$PLX glad i held on..this is going LOW on monday. ceo has NO shares now..dont blame them, i would have done the same
about 27 days ago by gotgame83
about 27 days ago by gotgame83
$PLX why do people think the pfe is going to buy them out? dont they already have a partnership with them? any benefit for pfe?
about 27 days ago by gotgame83
about 27 days ago by gotgame83
$PLX last minute buying ahed of "weekend buyout" comical...
about 27 days ago by johnkelly
about 27 days ago by johnkelly
Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); U.S. Tali Approval May Unlock Potential
Apr 19, 9:14AM Street Insider
Apr 19, 9:14AM Street Insider
Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
Mar 16, 4:01PM GlobeNewswire
Mar 16, 4:01PM GlobeNewswire
Auriga Reiterate a 'Buy' on Protalix BioTherapeutics (PLX); No Material Changes in 10-K
Mar 01, 10:42AM Street Insider
Mar 01, 10:42AM Street Insider
Protalix BioTherapeutics to Participate at Two Upcoming Global Healthcare Conferences
Feb 23, 7:30AM GlobeNewswire
Feb 23, 7:30AM GlobeNewswire
Protalix BioTherapeutics Announces Closing of Public Offering and Exercise of Over-Allotment Option
Feb 22, 4:15PM GlobeNewswire
Feb 22, 4:15PM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PLX | 6.14 | -0.21 | -3.31% | 576.71M |
| SONC | 8.28 | +0.01 | +0.12% | 500.75M |
| SON | 30.48 | -0.33 | -1.07% | 3.098B |
| SOMX | 0.30 | +0.01 | +3.45% | 13.95M |
| SOMH | 8.50 | +0.00 | +0.00% | 45.39M |
| SOL | 1.24 | -0.02 | -1.59% | 109.43M |
| SOHU | 43.01 | -1.76 | -3.93% | 1.705B |
| SOFO | 7.200 | -0.00 | -0.00% | 27.72M |
| SNSS | 2.90 | -0.11 | -3.65% | 140.93M |
| SNPS | 29.14 | -0.41 | -1.39% | 4.308B |